| Nature – CNIO Cancer Symposium on: Frontiers in Tumour Heterogeneity and Plasticity | The Nature — CNIO Cancer Symposium on Frontiers in Tumour Heterogeneity and Plasticity will coincide with the 10th anniversary of the inauguration of the CNIO. Tumour heterogeneity and plasticity have substantial implications for basic and clinical cancer research. To cover some of the most relevant and recent advances in this area, we have invited world leading experts to speak about: the cancer cell of origin, the clonal evolution of cancer, microenvironment and heterogeneity, tumour cell plasticity and tumour heterogeneity in the clinic. The program is aimed at setting the scene for the exchange of novel ideas and discussions on emerging molecular mechanisms of tumour heterogeneity and its clinical implications. | October 27-30, 2013 Madrid, Spain Register today Early registration ends today, July 31, 2013 KEYNOTE SPEAKERS: José Baselga (Massachusetts General Hospital Cancer Center, USA) Kornelia Polyak (Dana-Farber Cancer Institute, USA) | CONFIRMED SPEAKERS: Nicholas Barker Cédric Blanpain John Condeelis S. Gail Eckhardt Jeffrey Engelman Mike Hemann Christoph Klein Ross Levine Scott Lowe Hiroyuki Mano | Elaine Mardis Ruslan Medzhitov Sean Morrison Ángela Nieto Luis Parada Victoria Seewaldt Lillian Siu Charles Swanton Snorri Thorgeirsson Karen Vousden | | | SCIENTIFIC COMMITTEE: Mirna Peréz-Moreno (CNIO, Spain) Scott Lowe (Memorial Sloan-Kettering Cancer Center, USA) Erwin Wagner (CNIO, Spain) Barbara Marte (Nature, UK) Nicola McCarthy (Nature Reviews Cancer, UK) Alexia-Ileana Zaromytidou (Nature Cell Biology, USA) | | | | | |
No comments:
Post a Comment